Deep Track Capital, LP Nuvation Bio Inc. Transaction History

Deep Track Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.6 - $2.48 $800,800 - $1.24 Million	-500,500 Reduced 6.09%	7,720,688 $12.8 Million
Q4 2022 Feb 14, 2023	SELL	$1.68 - $2.5 $1.86 Million - $2.76 Million	-1,104,352 Reduced 11.84%	8,221,188 $15.8 Million
Q3 2022 Nov 14, 2022	SELL	$0.29 - $4.04 $622,264 - $8.67 Million	-2,145,741 Reduced 18.71%	9,325,540 $20.9 Million
Q2 2022 Aug 12, 2022	BUY	$3.24 - $5.85 $33.4 Million - $60.3 Million	10,315,789 Added 892.76%	11,471,281 $37.2 Million
Q1 2022 May 16, 2022	BUY	$4.6 - $8.83 $5.32 Million - $10.2 Million	1,155,492 New	1,155,492 $6.08 Million

152

123M

9.7K

6.5K

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $480M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.